Package 62135-901-60

Brand: rivastigmine tartrate

Generic: rivastigmine tartrate
NDC Package

Package Facts

Identity

Package NDC 62135-901-60
Digits Only 6213590160
Product NDC 62135-901
Product ID 62135-901_070bd281-9772-c587-e063-6294a90a04a2
Description

60 CAPSULE in 1 BOTTLE (62135-901-60)

Marketing

Marketing Status
Marketed Since 2023-01-04
Brand rivastigmine tartrate
Generic rivastigmine tartrate
Sample Package No

Linked Drug Pages (1)

Rivastigmine Tartrate ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "070bd281-9772-c587-e063-6294a90a04a2", "openfda": {"upc": ["0362135901608", "0362135903602", "0362135902605", "0362135900601"], "unii": ["9IY2357JPE"], "rxcui": ["312835", "312836", "314214", "314215"], "spl_set_id": ["2bb5e0d6-f677-4021-9888-3ff90979ef7d"], "manufacturer_name": ["Chartwell RX, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 CAPSULE in 1 BOTTLE (62135-901-60)", "package_ndc": "62135-901-60", "marketing_start_date": "20230104"}], "brand_name": "Rivastigmine Tartrate", "product_id": "62135-901_070bd281-9772-c587-e063-6294a90a04a2", "dosage_form": "CAPSULE", "pharm_class": ["Cholinesterase Inhibitor [EPC]", "Cholinesterase Inhibitors [MoA]"], "product_ndc": "62135-901", "generic_name": "Rivastigmine Tartrate", "labeler_name": "Chartwell RX, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Rivastigmine Tartrate", "active_ingredients": [{"name": "RIVASTIGMINE TARTRATE", "strength": "3 mg/1"}], "application_number": "ANDA207797", "marketing_category": "ANDA", "marketing_start_date": "20170928", "listing_expiration_date": "20261231"}